St. Jude Medical (NYSE:STJ) topped expectations on Wall Street with its 4th-quarter and 2013 results, prompting early-bird investors to send share prices up today in pre-market trading.
Q4
Investors balk at J&J’s 2014 guidance despite Q4, 2013 growth
Johnson & Johnson (NYSE:JNJ) shares are down this morning after the healthcare conglomerate said it expects its 2014 earnings to be a penny below expectations and posted strong sales and profit growth for the 4th quarter and 2013.
GE Healthcare grows profits among declining sales in Q4 and 2013
Globus Medical gains a bit on strong Q4 prelims
Globus Medical (NYSE:GMED) blew the doors off of the sluggish growth rate for the spinal implant market during the 4th quarter, topping Wall Street’s expectations and sending share prices up today.
HeartWare slides on missed Q4 prelims
HeartWare International (NSDQ:HTWR) said it expects to report 4th-quarter revenues of roughly $53 million, missing the consensus view on Wall Street of $58 million and sending its share price down sharply in pre-market trading.
Diabetes: DexCom’s Q4 prelims beat The Street, shares tick down anyway
Dexcom Inc. (NSDQ:DXCM) shares closed down a hair today despite Wall Street-beating preliminary 4th-quarter sales numbers for the medical device company.
NxStage Medical’s Q4 prelims beat its own, Wall Street’s forecasts
NxStage Medical (NSDQ:NXTM) saw its stock price climb this morning after reporting preliminary 4th-quarter sales numbers that topped its own forecast and handily beat expectations on Wall Street.
Intuitive Surgical’s Q4 prelims beat expectations, sending shares up
Intuitive Surgical (NSDQ:ISRG) topped Wall Street’s expectations for its 4th-quarter sales, sending share prices up today ahead of CEO Gary Guthart’s presentation at the J.P. Morgan Healthcare conference.